What is the ACC Innovation Program?

The ACC Innovation Program is working to lead the digital transformation of cardiovascular health care delivery. Under the guidance of the College’s Strategic Plan, the ACC Innovation Program ties together surveillance, engagement, thought leadership, and collaborations with industry and academic institutions to improve cardiovascular care. The team relies on the experience and expertise of the ACC membership to advance projects and initiatives that ultimately optimize cardiovascular care and outcomes.

Message From the Chair

Message From Richard Chazal, MD, MACC – Chair of the Innovation Development Work Group

The College recognizes its responsibility in bringing a clinical view and a patient voice to medical innovation, toward the goal of improved patient care. This alignment with our Mission "to improve heart health," prompted the Board of Trustees to form an innovation group overseen by senior leaders. Drs. Mike Mack, Hadley Wilson, Ed Fry, Fred Masoudi and I comprise the Innovation Development Work Group and are responsible for overseeing this work, which is led by Dr. John Rumsfeld and an exceptionally gifted team. It is our goal to search for, aid and promote the development of technologies that will enable our members to advance the care of their patients. Where appropriate, the ACC will invest time and resources (and, occasionally, financially) to help ensure success. This engagement of the clinical and research community with private enterprise is one of the ways that the College is working to provide useful tools and member value.

Rick Chazal, MD, MACC
Chair, Innovation Development Workgroup
Past President, ACC

Collaborators

Tech Collaborators

Strategic Collaborators

ACC Innovation Program Events

Institute for Computational Health Applied Artificial Intelligence (AI) Symposium

The American College of Cardiology (ACC) convened the Institute for Computational Health Applied Artificial Intelligence (AI) Symposium on December 4, 2019. The invitation-only event brought together representatives from medical professional societies, industry, patient/consumer driven organizations, hospitals/health systems and other stakeholders to discuss current challenges in the application of artificial intelligence to improve cardiovascular care and optimize health outcomes. The Institute for Computational Health (ICH), a joint effort between the American College of Cardiology (ACC) and the Yale University Center for Outcomes Research and Evaluation, hosted the event at the ACC Heart House in Washington, DC.

The Symposium was led by ACC's Chief Innovation Officer and Chief Science and Quality Officer John S. Rumsfeld, MD, PhD, FACC, as well as Vice President: Dipti Itchhaporia, MD, FACC, and Harlan Krumholz, MD, SM, FACC. Other member participants included ACC Innovation Council members Heba Wassif, MD, FACC, and Jai Nahar, MD, FACC, as well as ACC members Rohan Khera, MD, FACC, Freddy Abnousi, MD, FACC, and Khurram Nasir, MD, FACC.

Click Images to Enlarge

Disruptive Innovations in Health Care Conference

The ACC collaborated with the Consumer Technology Association (CTA) on the Disruptive Innovations in Health Care track at this year’s CES (Consumer Electronics Show) conference in Las Vegas, held on Jan. 7-10. These photos feature ACC's Chief Innovation Officer and Chief Science and Quality Officer John S. Rumsfeld, MD, PhD, FACC, as well as ACC member panelists: Dipti Itchhaporia, MD, FACC, Thomas Maddox, MD, MSc, FAC, and Ami Bhatt, MD, FACC.